Dr. Tom Van Der Hulle

This study tested if taking the kidney cancer drug cabozantinib with a light breakfast, instead of on an empty stomach, could make treatment easier and more effective. Researchers enrolled 12 patients to compare how the drug was absorbed by the body under both conditions. The goa…